when did retatrutide come out Retatrutide vs Ozempic: Clinical Trial

For a patient on metformin and insulin degludec who cannot use GLP-1 receptor agonists due to pancreatitis history, add an SGLT2 inhibitor with proven cardio...

Summary The use of GLP-2 analogs is effective in the management of SBS-IF and may show promise in the treatment of other severe gastrointestinal disorders associated with loss of effective intestinal resorptive surface area.

Discover current prescription statistics, usage trends, patient demographics, and access patterns for GLP-1 receptor agonists in the US healthcare system.

A large, randomized controlled trial comparing three time-restricted eating (TRE) windows found that time-restricted eating at any time of day is a promising strategy for losing weight but does not reduce visceral adipose tissue.

A 2026 informational evaluation of MEDVi's GLP-1 weight loss program structure, compounded semaglutide and branded Ozempic access pathways, published pricing disclosures, three-entity telehealth model, refund terms, and the regulatory and disclosure context relevant to online GLP-1 treatment programs

Impacto en la glucemia perioperatoria